Literature DB >> 15083765

Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation.

F Bühling1, N Waldburg, A Reisenauer, A Heimburg, H Golpon, T Welte.   

Abstract

Lysosomal cysteine proteases are a family comprising > 10 enzymes. For many years it was believed that these enzymes catalyse protein breakdown unselectively, are highly redundant in their substrate specificity and are also expressed ubiquitously. This view has changed dramatically since a number of new lysosomal cysteine proteases with restricted expression and outstanding enzymatic activity have been described. In addition, knockout mice and selective protease inhibitors have been used to characterise specific functions of single proteases. In this review, some of these functions are discussed in relation to the lungs, especially the role of lysosomal cysteine proteases in matrix remodelling, immunoregulation and surfactant protein processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083765     DOI: 10.1183/09031936.04.00105304

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  Revisiting the Principles of Designing a Vaccine.

Authors:  Shubhranshu Zutshi; Sunil Kumar; Prashant Chauhan; Bhaskar Saha
Journal:  Methods Mol Biol       Date:  2022

2.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

3.  Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation.

Authors:  Svetlana P Chapoval; Chun Geun Lee; Chuyan Tang; Achsah D Keegan; Lauren Cohn; Kim Bottomly; Jack A Elias
Journal:  Clin Immunol       Date:  2009-06-24       Impact factor: 3.969

4.  Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Clément Naudin; Alix Joulin-Giet; Gérard Couetdic; Patrick Plésiat; Aneta Szymanska; Emilia Gorna; Francis Gauthier; Franciszek Kasprzykowski; Fabien Lecaille; Gilles Lalmanach
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

5.  Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis.

Authors:  Andriy O Samokhin; Jacques Yves Gauthier; M David Percival; Dieter Brömme
Journal:  Respir Res       Date:  2011-01-20

6.  The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation.

Authors:  Kai Fan; Daobo Li; Yanli Zhang; Chao Han; Junjie Liang; Changyi Hou; Hongliang Xiao; Kazuhiro Ikenaka; Jianmei Ma
Journal:  J Neuroinflammation       Date:  2015-03-19       Impact factor: 8.322

7.  A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.

Authors:  Annika Kratzel; Jenna N Kelly; Philip V'kovski; Jasmine Portmann; Yannick Brüggemann; Daniel Todt; Nadine Ebert; Neeta Shrestha; Philippe Plattet; Claudia A Staab-Weijnitz; Albrecht von Brunn; Eike Steinmann; Ronald Dijkman; Gert Zimmer; Stephanie Pfaender; Volker Thiel
Journal:  PLoS Biol       Date:  2021-12-28       Impact factor: 8.029

8.  Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S.

Authors:  Silke Haerteis; Matteus Krappitz; Marko Bertog; Annabel Krappitz; Vera Baraznenok; Ian Henderson; Erik Lindström; Jane E Murphy; Nigel W Bunnett; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2012-08-05       Impact factor: 3.657

Review 9.  Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.

Authors:  Andrew J Thorley; Teresa D Tetley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases.

Authors:  Nicole Hofmann; Dmitry Galetskiy; Daniela Rauch; Thomas Wittmann; Andreas Marquardt; Matthias Griese; Ralf Zarbock
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.